Healthcare boards and investors have spent recent years worrying about the shrinking supply of executives willing to take the top jobs. That's a real problem. Yet a quieter, more consequential shift is happening at the same time, and it's getting far less attention: the industry's own definition of who is "ready" to lead is being rewritten, and many executive search processes haven't caught up to this new reality.
For decades, healthcare leadership in the hospital setting followed a predictable pipeline. Rise through operations or clinical leadership, log a decade or more inside one or two health systems, earn a COO title, wait for a board to bet on you or for a search professional to call. Tenure was the credential. Time in seat signaled judgment; judgment and years of experience signaled readiness. That pipeline produced generations of steady operators—and it's now colliding with a pace of change it was never built to evaluate for.
Across industries, boards are shifting from experience-based evaluation to skills-based evaluation, asking not "have you done this before?" but "can you do what this moment requires?" That shift shows up starkly in the data. AI now appears in roughly 27% of C-suite job descriptions, up from under 10% just two years ago. Fully 93% of Fortune 500 CHROs report their organizations have already deployed AI tools. And 57% of hospital and health system C-suite leaders now rank AI-based clinical solutions as their top technology priority over the next two years. That doesn’t even begin to capture AI’s impact when you consider AI-based business solutions, too, which are already having a huge impact in RCM and other functional areas critical to the survival (and success) of every hospital organization and provider group of scale.
None of that means boards are suddenly hiring data scientists and engineers to run hospitals. What it means is that the traditional proxy for readiness—years spent inside a system doing things the way they've always been done—no longer reliably predicts who can lead one through what's coming next. A leader who spent fifteen years perfecting operations under the old model isn't automatically the person best equipped to redesign that model around AI-enabled care delivery, workforce automation, and a regulatory environment being rewritten in real time.
We will have more to say on this topic, but I want to be clear—operational excellence and discipline are still absolutely critical to the success of any healthcare organization. Nowhere is this more true than in the hospital industry. In fact, one could argue that innovation is a nice-to-have while operating acumen is a must-have. Yet with the rapid deterioration in coverage and continued compression in commercial payment rates, innovation and AI fluency are becoming must-haves, too. It’s not either/or; it’s “yes, and…”
More on operational excellence in a follow-on piece of content coming soon.
Here's the uncomfortable part: many boards and investors are no better prepared to evaluate this than the executives they're vetting. That’s not criticism; it’s merely a function of how new these skill sets are and how fast they’re changing. A McKinsey assessment of the Fortune 100 found only 39% of companies have any form of board-level AI oversight—a committee, a director with real AI expertise, or an ethics function. Healthcare boards, dominated by clinical, financial, and legal expertise, skew even further from that baseline. That leaves many search committees running 2022-era evaluation criteria against a 2026 leadership problem: screening for polish and pedigree in an interview process that never tests for one of the things that will actually determine whether this person succeeds—how they think under technological and operational ambiguity they haven't seen before.
This is a solvable problem, but not by adding "AI experience" as a checkbox to a job description, which is what a lot of organizations are doing. The executive`recruiters closest to this shift report a real disconnect: when surveyed on their top hiring priority for 2026, talent leaders rank critical thinking first—AI fluency ranks fifth. The point isn't finding someone who can speak with confidence and knowledge about large language models. It's finding someone with the judgment to make sound strategic calls in an AI-augmented environment and bring a skeptical, exhausted workforce along with them. That's a much harder thing to screen for than a résumé line.
The organizations getting this right aren't lowering their standards—they're widening who they're willing to consider meeting those standards. Boards that once required a linear, in-system pipeline are now taking serious looks at leaders who built their judgment somewhere else: digital health operators, technology executives with genuine healthcare fluency, leaders who've run smaller, faster-moving organizations through a full cycle of ambiguity rather than a large one through a period of stability.
Demand for product and engineering leadership inside health systems has grown so sharply that healthcare organizations are now competing directly with technology companies for the same talent, a competition that didn't meaningfully exist five years ago.
This doesn't mean clinical and operational depth stop mattering. They still anchor trust with physicians, staff, and patients in a way no amount of technology fluency replaces. Yet depth in one dimension is no longer sufficient on its own, and boards that keep screening for it exclusively are shrinking their own candidate pool at the exact moment they can least afford to.
There is an argument for evaluating capability and judgment over pedigree, which has always been the harder, slower, more honest way to run an executive search (and the reason it hasn't been the default within much of the search industry). It's easier to shortlist candidates by title and tenure than to actually assess how someone reasons through a problem they've never faced. Yet it's the only approach that holds up when jobs change faster than any resume can document.
It's also, not coincidentally, the model that the team at Oxeon has built its search work around for 15 years, evaluating leaders on judgment, adaptability, business model familiarity, and demonstrated impact rather than defaulting to the safest-looking résumé. A non-linear path used to be the exception that boards and investors occasionally made room for. Increasingly, it's simply what exceptional leadership in healthcare looks like.
Once upon a time, hospitals avoided using commercial terms like “growth” at a time the investor-backed healthcare arena prioritized exactly that. Now, with the ACA rollback and deep Medicaid cuts looming, combined with the inflationary environment and decreasing yields in MA and commercial payments from insurance companies, hospital executives are adapting their talk track. Growth, especially with the commercially insured population, combined with operational excellence, is the only way to weather the slow-moving storm that is arriving one rain cloud at a time.
The organizations that will win the next five years of healthcare leadership aren't the ones that find a way to convince more executives to take the CEO job, though that matters. They're the ones that first do the harder work of updating what "qualified" actually means—before they go looking for who fits these criteria. Boards that keep running searches against a pipeline built for a slower era will keep coming up with the same candidates with the same resumes, not because good leaders don't exist, but because their process is filtering them out before it ever gets to see them.
Brandon Edwards is a partner at Oxeon, joining the firm after a 35-year career in healthcare as an entrepreneur, marketing expert, and CEO for nearly two decades. Brandon focuses on growing the talent pool of healthcare executives serving the investor-backed and nonprofit sectors, with a special expertise in marketing and managed care searches. He can be reached at brandon@oxeon.com.
